Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
A prospective cohort of direct-to-consumer genetic testing customers: Consumer motivations, behavioral responses, and the impact on the health care system
EF 2012-13
Résumé
Direct-to-consumer genetic testing (DTC-GT) - purchased through private genomics companies without the involvement of one's physician - is increasingly popular. Today, DTC-GT refers to the analysis of specific genetic variants associated with an increased or decreased disease risk. Soon, DTC-GT companies will expand their offerings to include whole genome sequencing, permitting analysis of an individual's complete genetic code. Little empirical data exists regarding the motivations of consumers, the ability of DTC-GT to improve health, or its impact on the health system; however, the Canadian College of Medical Geneticists has warned of the potential for DTC-GT to drain public resources without improving patient care. The Impact of Personal Genomes study at Brigham & Women's Hospital (Boston MA) has compiled, in cooperation with two commercial genomics companies, a sample of 1 740 DTC-GT customers. Study participants have completed 3 surveys: one prior to testing, another shortly after receiving their results, and a third 6 months later. Data has been collected regarding motivations, health/family history, health behaviors, genetic knowledge, risk perception, emotional impact, and health service use. My research will investigate why customers choose to undergo DTC-GT, the impact of DTC-GT on personal health and the health system, and the role of genetic literacy (functional genetic knowledge) on these outcomes. I will also define factors that predict whether or not, after testing, consumers: (1) discuss their results with a physician, (2) modify health behaviors, and (3) receive additional screening or specialist health services. An understanding of consumer motivations, the role of genetic literacy, and the impact of DTC-GT on the health care system will facilitate the development of informed and appropriate practice guidelines and regulatory policies in the United States and Canada.
Programme
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
283771
Name
Carere Deanna Alexis M
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
A prospective cohort of direct-to-consumer genetic testing customers: Consumer motivations, behavioral responses, and the impact on the health care system
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Clinical Utility; Direct-To-Consumer; Ethical; Genetic Testing; Genomics; Health Literacy; Legal And Social Issues; Personalized Medicine; Psychosocial; Risk Assessment; Screening
Abstract
Direct-to-consumer genetic testing (DTC-GT) - purchased through private genomics companies without the involvement of one's physician - is increasingly popular. Today, DTC-GT refers to the analysis of specific genetic variants associated with an increased or decreased disease risk. Soon, DTC-GT companies will expand their offerings to include whole genome sequencing, permitting analysis of an individual's complete genetic code. Little empirical data exists regarding the motivations of consumers, the ability of DTC-GT to improve health, or its impact on the health system; however, the Canadian College of Medical Geneticists has warned of the potential for DTC-GT to drain public resources without improving patient care. The Impact of Personal Genomes study at Brigham & Women's Hospital (Boston MA) has compiled, in cooperation with two commercial genomics companies, a sample of 1 740 DTC-GT customers. Study participants have completed 3 surveys: one prior to testing, another shortly after receiving their results, and a third 6 months later. Data has been collected regarding motivations, health/family history, health behaviors, genetic knowledge, risk perception, emotional impact, and health service use. My research will investigate why customers choose to undergo DTC-GT, the impact of DTC-GT on personal health and the health system, and the role of genetic literacy (functional genetic knowledge) on these outcomes. I will also define factors that predict whether or not, after testing, consumers: (1) discuss their results with a physician, (2) modify health behaviors, and (3) receive additional screening or specialist health services. An understanding of consumer motivations, the role of genetic literacy, and the impact of DTC-GT on the health care system will facilitate the development of informed and appropriate practice guidelines and regulatory policies in the United States and Canada.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Carere, Deanna Alexis M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~